Fukutin antibody (Middle Region)
Quick Overview for Fukutin antibody (Middle Region) (ABIN952403)
Target
See all Fukutin (FKTN) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 184-214, Middle Region
-
Specificity
- This antibody recognizes Human and Mouse FKTN (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 184-214 amino acids from the Central region of Human Fukutin. Genename: FKTN
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Fukutin (FKTN)
-
Alternative Name
- Fukutin
-
Background
- The protein encoded by this gene is a putative transmembrane protein that is localized to the cis-Golgi compartment, where it may be involved in the glycosylation of alpha-dystroglycan in skeletal muscle. The encoded protein is thought to be a glycosyltransferase and could play a role in brain development. Defects in this gene are a cause of Fukuyama-type congenital muscular dystrophy (FCMD), Walker-Warburg syndrome (WWS), limb-girdle muscular dystrophy type 2M (LGMD2M), and dilated cardiomyopathy type 1X (CMD1X). Alternatively spliced transcript variants have been found for this gene.Synonyms: FCMD, FKTN, Fukuyama-type congenital muscular dystrophy protein
-
Molecular Weight
- 53724 Da
-
Gene ID
- 2218
-
NCBI Accession
- NP_001073270
-
Pathways
- Regulation of Carbohydrate Metabolic Process
Target
-